RTOG 95-17, a Phase II trial to evaluate brachytherapy as the sole method of radiation therapy for Stage I and II breast carcinoma—year-5 toxicity and cosmesis
2013 · Brachytherapy · 66 citations
https://doi.org/10.1016/j.brachy.2013.08.002
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
118
Papers
4.4K
Citations
36
h-index
72
i10-index
John S. Bolton is an academic researcher. The author has contributed to research in topics: Breast Cancer Treatment Studies & Breast Lesions and Carcinomas & Esophageal and GI Pathology. The author has an h-index of 36, co-authored 101 publications.
https://doi.org/10.1016/j.brachy.2013.08.002
https://doi.org/10.1016/j.vgie.2018.07.018
https://doi.org/10.1016/s0016-5085(24)03498-x
Click to start Chat